在SH-SY5Y人神经母细胞瘤细胞中,gq偶联毒蕈碱乙酰胆碱受体刺激可增强Midnolin基因表达

IF 2.9 3区 医学 Q2 PHARMACOLOGY & PHARMACY Journal of pharmacological sciences Pub Date : 2025-04-01 Epub Date: 2025-02-23 DOI:10.1016/j.jphs.2025.02.006
Ikuo Norota , Yusuke Zuiki , Ayano Chiba , Mikako Nagashima , Jiro Ogura , Hiroaki Yamaguchi , Kuniaki Ishii , Yutaro Obara
{"title":"在SH-SY5Y人神经母细胞瘤细胞中,gq偶联毒蕈碱乙酰胆碱受体刺激可增强Midnolin基因表达","authors":"Ikuo Norota ,&nbsp;Yusuke Zuiki ,&nbsp;Ayano Chiba ,&nbsp;Mikako Nagashima ,&nbsp;Jiro Ogura ,&nbsp;Hiroaki Yamaguchi ,&nbsp;Kuniaki Ishii ,&nbsp;Yutaro Obara","doi":"10.1016/j.jphs.2025.02.006","DOIUrl":null,"url":null,"abstract":"<div><div>We previously demonstrated that the midnolin gene (<em>MIDN</em>) is a risk factor for Parkinson's disease (PD) in Yamagata and British cohorts, and that neurite outgrowth is abolished by <em>MIDN</em> knockout in PC12 cells. Therefore, drugs that upregulate <em>MIDN</em> may have neurotrophic effects. In this study, acetylcholine increased <em>MIDN</em> promoter activity and gene expression in a concentration-dependent manner in SH-SY5Y cells. These effects were suppressed by atropine and a G<sub>q</sub> inhibitor, YM254890, indicating that muscarinic receptor/G<sub>q</sub> signaling is required for the induction of <em>MIDN</em> by acetylcholine. Our findings suggest that drugs that upregulate <em>MIDN</em> may have therapeutic potential for PD.</div></div>","PeriodicalId":16786,"journal":{"name":"Journal of pharmacological sciences","volume":"157 4","pages":"Pages 229-232"},"PeriodicalIF":2.9000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Midnolin gene expression is enhanced by Gq-coupled muscarinic acetylcholine receptor stimulation in SH-SY5Y human neuroblastoma cells\",\"authors\":\"Ikuo Norota ,&nbsp;Yusuke Zuiki ,&nbsp;Ayano Chiba ,&nbsp;Mikako Nagashima ,&nbsp;Jiro Ogura ,&nbsp;Hiroaki Yamaguchi ,&nbsp;Kuniaki Ishii ,&nbsp;Yutaro Obara\",\"doi\":\"10.1016/j.jphs.2025.02.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>We previously demonstrated that the midnolin gene (<em>MIDN</em>) is a risk factor for Parkinson's disease (PD) in Yamagata and British cohorts, and that neurite outgrowth is abolished by <em>MIDN</em> knockout in PC12 cells. Therefore, drugs that upregulate <em>MIDN</em> may have neurotrophic effects. In this study, acetylcholine increased <em>MIDN</em> promoter activity and gene expression in a concentration-dependent manner in SH-SY5Y cells. These effects were suppressed by atropine and a G<sub>q</sub> inhibitor, YM254890, indicating that muscarinic receptor/G<sub>q</sub> signaling is required for the induction of <em>MIDN</em> by acetylcholine. Our findings suggest that drugs that upregulate <em>MIDN</em> may have therapeutic potential for PD.</div></div>\",\"PeriodicalId\":16786,\"journal\":{\"name\":\"Journal of pharmacological sciences\",\"volume\":\"157 4\",\"pages\":\"Pages 229-232\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of pharmacological sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1347861325000167\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1347861325000167","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

我们之前在Yamagata和British队列中证明midnolin基因(MIDN)是帕金森病(PD)的一个危险因素,并且PC12细胞中的MIDN敲除会消除神经突的生长。因此,上调MIDN的药物可能具有神经营养作用。在本研究中,乙酰胆碱在SH-SY5Y细胞中以浓度依赖性的方式增加MIDN启动子活性和基因表达。这些作用被阿托品和Gq抑制剂YM254890抑制,表明乙酰胆碱诱导MIDN需要毒蕈碱受体/Gq信号。我们的研究结果表明,上调MIDN的药物可能具有治疗PD的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Midnolin gene expression is enhanced by Gq-coupled muscarinic acetylcholine receptor stimulation in SH-SY5Y human neuroblastoma cells
We previously demonstrated that the midnolin gene (MIDN) is a risk factor for Parkinson's disease (PD) in Yamagata and British cohorts, and that neurite outgrowth is abolished by MIDN knockout in PC12 cells. Therefore, drugs that upregulate MIDN may have neurotrophic effects. In this study, acetylcholine increased MIDN promoter activity and gene expression in a concentration-dependent manner in SH-SY5Y cells. These effects were suppressed by atropine and a Gq inhibitor, YM254890, indicating that muscarinic receptor/Gq signaling is required for the induction of MIDN by acetylcholine. Our findings suggest that drugs that upregulate MIDN may have therapeutic potential for PD.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.20
自引率
2.90%
发文量
104
审稿时长
31 days
期刊介绍: Journal of Pharmacological Sciences (JPS) is an international open access journal intended for the advancement of pharmacological sciences in the world. The Journal welcomes submissions in all fields of experimental and clinical pharmacology, including neuroscience, and biochemical, cellular, and molecular pharmacology for publication as Reviews, Full Papers or Short Communications. Short Communications are short research article intended to provide novel and exciting pharmacological findings. Manuscripts concerning descriptive case reports, pharmacokinetic and pharmacodynamic studies without pharmacological mechanism and dose-response determinations are not acceptable and will be rejected without peer review. The ethnopharmacological studies are also out of the scope of this journal. Furthermore, JPS does not publish work on the actions of biological extracts unknown chemical composition.
期刊最新文献
Viral infection and establishing new therapeutic platforms– On the occasion of receiving the 16th Setsuro Ebashi award – Minocycline inhibits endothelin-1-induced contraction in isolated pulmonary artery Enhanced effect of the hallucinogen DOI in L-DOPA receptor Gpr143-deficient mice Myricetin inhibits vascular calcification in an in vitro model by modulating ferroptosis-related SLC7A11/GPX4 signaling Development and application of a method for quantitative monitoring of Isepamicin concentration in human plasma based on liquid chromatography-mass spectrometry
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1